Pascal and Francis Bibliographic Databases

Help

Permanent link : http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=18687095

Export

Selection :

Fampridine-SR in multiple sclerosis : a randomized, double-blind, placebo-controlled, dose-ranging study

Author
GOODMAN, A. D1 ; COHEN, J. A2 ; CROSS, A3 ; VOLLMER, T4 ; RIZZO, M4 ; COHEN, R5 ; MORINUCCI, L5 ; BLIGHT, A. R5
[1] Department of Neurology, University of Rochester, Rochester, NY 14642, United States
[2] Department of Neurology, Mellen Center, Cleveland Clinic Foundation, Cleveland, OH 44195, United States
[3] Department of Neurology, Washington University, St Louis, MO 63110, United States
[4] Department of Neurology, Yale University, New Haven, CT 06520, United States
[5] Acorda Therapeutics, Inc, Hawthorne, NY 10532, United States
Source

Multiple sclerosis. 2007, Vol 13, Num 3, pp 357-368, 12 p ; ref : 29 ref

ISSN
1352-4585
Scientific domain
Neurology
Publisher
Arnold, London
Publication country
United Kingdom
Document type
Article
Language
English
Author keyword
4-aminopyridine Fampridine-SR clinical trial multiple sclerosis safety
Keyword (fr)
Amélioration Asthénie Complication Convulsion Céphalée Douleur Essai clinique Etude double insu Extrémité inférieure Fampridine Fatigue Forme libération contrôlée Hebdomadaire Homme Insomnie Maladie dégénérative Manuel Marche à pied Nausée Paresthésie Placebo Pronostic Prospective Questionnaire Résistance mécanique Sclérose en plaques Système nerveux pathologie Sécurité Tremblement Vertige Vitesse déplacement Locomotion Maladie inflammatoire Mouvement involontaire ORL pathologie Système nerveux central pathologie Trouble neurologique Trouble sensibilité Trouble sommeil Trouble équilibre
Keyword (en)
Improvement Asthenia Complication Convulsion Headache Pain Clinical trial Double blind study Lower extremity Fampridine Fatigue Controlled release form Weekly Human Insomnia Degenerative disease Manuals Walking Nausea Paresthesia Placebo Prognosis Prospective Questionnaire Strength Multiple sclerosis Nervous system diseases Safety Tremor Vertigo Speed Locomotion Inflammatory disease Involuntary movement ENT disease Central nervous system disease Neurological disorder Sensitivity disorder Sleep disorder Equilibrium disorder
Keyword (es)
Mejora Astenia Complicación Convulsión Cefalea Dolor Ensayo clínico Estudio doble ciego Extremidad inferior Fampridina Fatiga Forma liberación controlada Semanal Hombre Insomnio Enfermedad degenerativa Manual Caminata Nausea Parestesia Placebo Pronóstico Prospectiva Cuestionario Resistencia mecánica Esclerosis en placa Sistema nervioso patología Seguridad Temblor Vértigo Velocidad desplazamiento Locomoción Enfermedad inflamatoria Movimiento involuntario ORL patología Sistema nervosio central patología Trastorno neurológico Trastorno sensibilidad Trastorno sueño Trastorno equilibrio
Classification
Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02Q Immunomodulators

Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B17 Neurology / 002B17F Multiple sclerosis and variants. Guillain barré syndrome and other inflammatory polyneuropathies. Leukoencephalitis

Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B17 Neurology / 002B17G Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases

Discipline
Neurology Pharmacological treatments
Origin
Inist-CNRS
Database
PASCAL
INIST identifier
18687095

Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS

Access to the document

Searching the Web